MARKET

BIO

BIO

Bio Rad Labs Inc
NYSE
370.48
-15.52
-4.02%
Closed 19:30 11/12 EST
OPEN
382.88
PREV CLOSE
386.00
HIGH
390.00
LOW
369.40
VOLUME
182.32K
TURNOVER
0
52 WEEK HIGH
396.23
52 WEEK LOW
236.73
MARKET CAP
9.96B
P/E (TTM)
9.76
1D
5D
1M
3M
1Y
5Y
1D
Bio-Rad Laboratories' (NYSE:BIO) Solid Profits Have Weak Fundamentals
Simply Wall St · 22h ago
Bio-Rad Laboratories Earnings Call Signals Cautious Recovery
TipRanks · 1d ago
Bio Rad Laboratories (BIO) Stock Could Be 23% Overvalued Despite Activist Pressure
Simply Wall St · 2d ago
Why Bio-Rad (BIO) International Revenue Trends Deserve Your Attention
NASDAQ · 3d ago
Weekly Report: what happened at BIO last week (1102-1106)?
Weekly Report · 3d ago
Bio Rad Laboratories (BIO) Could Be 14% Overvalued After Elliott Interest And Earnings
Simply Wall St · 4d ago
Is Revenue Growth Return Altering The Investment Case For Bio Rad Laboratories (BIO)?
Simply Wall St · 5d ago
The Bio-Rad Laboratories, Inc. (NYSE:BIO) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Simply Wall St · 6d ago
More
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Webull offers Bio-Rad Laboratories, Inc. stock information, including NYSE: BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIO stock methods without spending real money on the virtual paper trading platform.